TY - JOUR AU - Borg, A. AU - Tandon, A. K. AU - Sigurdsson, H. AU - Clark, G. M. AU - Fernö, M. AU - Fuqua, S. A. AU - Killander, D. AU - McGuire, W. L. PY - 1990 DA - 1990// TI - HER-2/neu amplification predicts poor survival in node-positive breast cancer JO - Cancer Res VL - 50 ID - Borg1990 ER - TY - JOUR AU - Elixhauser, A. AU - Steiner, C. AU - Harris, D. R. AU - Coffey, R. M. PY - 1998 DA - 1998// TI - Comorbidity measures for use with administrative data JO - Med Care VL - 36 UR - https://doi.org/10.1097/00005650-199801000-00004 DO - 10.1097/00005650-199801000-00004 ID - Elixhauser1998 ER - TY - BOOK PY - 2006 DA - 2006// TI - Trastuzumab prescribing information ID - ref3 ER - TY - BOOK PY - 2012 DA - 2012// TI - Pertuzumab prescribing information ID - ref4 ER - TY - BOOK PY - 2013 DA - 2013// TI - Ado-trastuzumab emtansine prescribing information ID - ref5 ER - TY - BOOK PY - 2007 DA - 2007// TI - Lapatinib prescribing information ID - ref6 ER - TY - CHAP AU - Gullo, G. AU - Bettio, D. AU - Zuradelli, M. AU - Masci, G. AU - Giordano, L. AU - Bareggi, C. AU - Tomirotti, M. AU - Salvini, P. AU - Runza, L. AU - La Verde, N. AU - Santoro, A. PY - 2013 DA - 2013// TI - Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy BT - Breast ID - Gullo2013 ER - TY - JOUR AU - Guy, C. T. AU - Webster, M. A. AU - Schaller, M. AU - Parsons, T. J. AU - Cardiff, R. D. AU - Muller, W. J. PY - 1992 DA - 1992// TI - Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease JO - Proc Natl Acad Sci U S A VL - 89 UR - https://doi.org/10.1073/pnas.89.22.10578 DO - 10.1073/pnas.89.22.10578 ID - Guy1992 ER - TY - JOUR AU - Kumar, V. AU - Tewari, M. AU - Singh, U. AU - Shukla, H. S. PY - 2007 DA - 2007// TI - Significance of Her-2/neu protein overexpression in Indian breast cancer patients JO - Indian J Surg VL - 69 UR - https://doi.org/10.1007/s12262-007-0002-8 DO - 10.1007/s12262-007-0002-8 ID - Kumar2007 ER - TY - BOOK AU - Mayer, M. PY - 2011 DA - 2011// TI - Living with advanced breast cancer: challenges and opportunities ID - Mayer2011 ER - TY - JOUR AU - Medina, P. J. AU - Goodin, S. PY - 2008 DA - 2008// TI - Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases JO - Clin Ther VL - 30 UR - https://doi.org/10.1016/j.clinthera.2008.08.008 DO - 10.1016/j.clinthera.2008.08.008 ID - Medina2008 ER - TY - JOUR AU - Montero, A. J. AU - Eapen, S. AU - Gorin, B. AU - Adler, P. PY - 2012 DA - 2012// TI - The economic burden of metastatic breast cancer: a U.S. managed care perspective JO - Breast Cancer Res Treat VL - 134 UR - https://doi.org/10.1007/s10549-012-2097-2 DO - 10.1007/s10549-012-2097-2 ID - Montero2012 ER - TY - BOOK PY - 2012 DA - 2012// TI - NCCN Guidelines Version 2. Breast cancer ID - ref13 ER - TY - BOOK PY - 2011 DA - 2011// TI - PharMetrics® Integrated Database ID - ref14 ER - TY - JOUR AU - Quan, H. AU - Sundararajan, V. AU - Halfon, P. AU - Fong, A. AU - Burnand, B. AU - Luthi, J. C. AU - Saunders, L. D. AU - Beck, C. A. AU - Feasby, T. E. AU - Ghali, W. A. PY - 2005 DA - 2005// TI - Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data JO - Med Care VL - 43 UR - https://doi.org/10.1097/01.mlr.0000182534.19832.83 DO - 10.1097/01.mlr.0000182534.19832.83 ID - Quan2005 ER - TY - JOUR AU - Siegel, R. AU - Ma, J. AU - Zou, Z. AU - Jemal, A. PY - 2014 DA - 2014// TI - Cancer statistics, 2014 JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21208 DO - 10.3322/caac.21208 ID - Siegel2014 ER - TY - JOUR AU - Slamon, D. J. AU - Clark, G. M. AU - Wong, S. G. AU - Levin, W. J. AU - Ullrich, A. AU - McGuire, W. L. PY - 1987 DA - 1987// TI - Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu ncogene JO - Science VL - 235 UR - https://doi.org/10.1126/science.3798106 DO - 10.1126/science.3798106 ID - Slamon1987 ER - TY - JOUR AU - Slamon, D. J. AU - Godolphin, W. AU - Jones, L. A. PY - 1989 DA - 1989// TI - Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer JO - Science VL - 244 UR - https://doi.org/10.1126/science.2470152 DO - 10.1126/science.2470152 ID - Slamon1989 ER - TY - JOUR AU - Slamon, D. J. AU - Leyland-Jones, B. AU - Shak, S. AU - Fuchs, H. AU - Paton, V. AU - Bajamonde, A. AU - Fleming, T. AU - Eiermann, W. AU - Wolter, J. AU - Pegram, M. AU - Baselga, J. AU - Norton, L. PY - 2001 DA - 2001// TI - Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103153441101 DO - 10.1056/NEJM200103153441101 ID - Slamon2001 ER - TY - BOOK PY - 2013 DA - 2013// TI - Breast cancer statistics ID - ref20 ER - TY - JOUR AU - Vera-Llonch, M. AU - Weycker, D. AU - Glass, A. AU - Gao, S. AU - Borker, R. AU - Qin, A. AU - Oster, G. PY - 2011 DA - 2011// TI - Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-250 DO - 10.1186/1471-2407-11-250 ID - Vera-Llonch2011 ER -